0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Coronary Intervention Drug Eluting Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-18X7805
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Coronary Intervention Drug Eluting Stent Market Insights Forecast to 2028
BUY CHAPTERS

Coronary Intervention Drug Eluting Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18X7805
Report
October 2024
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Coronary Intervention Drug Eluting Stent - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Coronary Intervention Drug Eluting Stent - Market

Coronary Intervention Drug Eluting Stent - Market

The global market for Coronary Intervention Drug Eluting Stent was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coronary Intervention Drug Eluting Stent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coronary Intervention Drug Eluting Stent by region & country, by Type, and by Application.
The Coronary Intervention Drug Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Intervention Drug Eluting Stent.
Market Segmentation

Scope of Coronary Intervention Drug Eluting Stent - Market Report

Report Metric Details
Report Name Coronary Intervention Drug Eluting Stent - Market
CAGR 5%
Segment by Type:
  • Below 40 µm
  • 40 µm- 65 µm
  • Above 65 µm
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Synlas GmbH, YILSON, BrosMed Medical, SCITECH Medical, Wellinq, Degania Silicone, Alvimedica, Interventional Medical Device Solutions, Comed BV, iVascular, LEPU Medical, Eurocor Tech GmbH, OrbusNeich, Endocor GmbH, Meril Life Sciences, Acrostak, Boston Scientific Corporation, B. Braun, Biotronik, Abbott, MicroPort Medical Group, Philips, Terumo Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Coronary Intervention Drug Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Coronary Intervention Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Coronary Intervention Drug Eluting Stent in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Coronary Intervention Drug Eluting Stent - Market report?

Ans: The main players in the Coronary Intervention Drug Eluting Stent - Market are Synlas GmbH, YILSON, BrosMed Medical, SCITECH Medical, Wellinq, Degania Silicone, Alvimedica, Interventional Medical Device Solutions, Comed BV, iVascular, LEPU Medical, Eurocor Tech GmbH, OrbusNeich, Endocor GmbH, Meril Life Sciences, Acrostak, Boston Scientific Corporation, B. Braun, Biotronik, Abbott, MicroPort Medical Group, Philips, Terumo Corporation

What are the Application segmentation covered in the Coronary Intervention Drug Eluting Stent - Market report?

Ans: The Applications covered in the Coronary Intervention Drug Eluting Stent - Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Coronary Intervention Drug Eluting Stent - Market report?

Ans: The Types covered in the Coronary Intervention Drug Eluting Stent - Market report are Below 40 µm, 40 µm- 65 µm, Above 65 µm

Recommended Reports

Cardiovascular Interventions

Cardiac Disease Drugs

Stents & Delivery Devices

1 Market Overview
1.1 Coronary Intervention Drug Eluting Stent Product Introduction
1.2 Global Coronary Intervention Drug Eluting Stent Market Size Forecast
1.2.1 Global Coronary Intervention Drug Eluting Stent Sales Value (2019-2030)
1.2.2 Global Coronary Intervention Drug Eluting Stent Sales Volume (2019-2030)
1.2.3 Global Coronary Intervention Drug Eluting Stent Sales Price (2019-2030)
1.3 Coronary Intervention Drug Eluting Stent Market Trends & Drivers
1.3.1 Coronary Intervention Drug Eluting Stent Industry Trends
1.3.2 Coronary Intervention Drug Eluting Stent Market Drivers & Opportunity
1.3.3 Coronary Intervention Drug Eluting Stent Market Challenges
1.3.4 Coronary Intervention Drug Eluting Stent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Coronary Intervention Drug Eluting Stent Players Revenue Ranking (2023)
2.2 Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2024)
2.3 Global Coronary Intervention Drug Eluting Stent Players Sales Volume Ranking (2023)
2.4 Global Coronary Intervention Drug Eluting Stent Sales Volume by Company Players (2019-2024)
2.5 Global Coronary Intervention Drug Eluting Stent Average Price by Company (2019-2024)
2.6 Key Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Coronary Intervention Drug Eluting Stent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Coronary Intervention Drug Eluting Stent
2.9 Coronary Intervention Drug Eluting Stent Market Competitive Analysis
2.9.1 Coronary Intervention Drug Eluting Stent Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Coronary Intervention Drug Eluting Stent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Intervention Drug Eluting Stent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Below 40 µm
3.1.2 40 µm- 65 µm
3.1.3 Above 65 µm
3.2 Global Coronary Intervention Drug Eluting Stent Sales Value by Type
3.2.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Coronary Intervention Drug Eluting Stent Sales Value, by Type (2019-2030)
3.2.3 Global Coronary Intervention Drug Eluting Stent Sales Value, by Type (%) (2019-2030)
3.3 Global Coronary Intervention Drug Eluting Stent Sales Volume by Type
3.3.1 Global Coronary Intervention Drug Eluting Stent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Type (2019-2030)
3.3.3 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Type (%) (2019-2030)
3.4 Global Coronary Intervention Drug Eluting Stent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Coronary Intervention Drug Eluting Stent Sales Value by Application
4.2.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Coronary Intervention Drug Eluting Stent Sales Value, by Application (2019-2030)
4.2.3 Global Coronary Intervention Drug Eluting Stent Sales Value, by Application (%) (2019-2030)
4.3 Global Coronary Intervention Drug Eluting Stent Sales Volume by Application
4.3.1 Global Coronary Intervention Drug Eluting Stent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Application (2019-2030)
4.3.3 Global Coronary Intervention Drug Eluting Stent Sales Volume, by Application (%) (2019-2030)
4.4 Global Coronary Intervention Drug Eluting Stent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Region
5.1.1 Global Coronary Intervention Drug Eluting Stent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2019-2024)
5.1.3 Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2025-2030)
5.1.4 Global Coronary Intervention Drug Eluting Stent Sales Value by Region (%), (2019-2030)
5.2 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region
5.2.1 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2019-2024)
5.2.3 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2025-2030)
5.2.4 Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (%), (2019-2030)
5.3 Global Coronary Intervention Drug Eluting Stent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
5.4.2 North America Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
5.5.2 Europe Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
5.6.2 Asia Pacific Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
5.7.2 South America Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
5.8.2 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value
6.2.1 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.2.2 Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.3.2 United States Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.4.2 Europe Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.5.2 China Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.5.3 China Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.6.2 Japan Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.7.2 South Korea Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.8.2 Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Coronary Intervention Drug Eluting Stent Sales Value, 2019-2030
6.9.2 India Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
6.9.3 India Coronary Intervention Drug Eluting Stent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Synlas GmbH
7.1.1 Synlas GmbH Company Information
7.1.2 Synlas GmbH Introduction and Business Overview
7.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offerings
7.1.5 Synlas GmbH Recent Development
7.2 YILSON
7.2.1 YILSON Company Information
7.2.2 YILSON Introduction and Business Overview
7.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 YILSON Coronary Intervention Drug Eluting Stent Product Offerings
7.2.5 YILSON Recent Development
7.3 BrosMed Medical
7.3.1 BrosMed Medical Company Information
7.3.2 BrosMed Medical Introduction and Business Overview
7.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offerings
7.3.5 BrosMed Medical Recent Development
7.4 SCITECH Medical
7.4.1 SCITECH Medical Company Information
7.4.2 SCITECH Medical Introduction and Business Overview
7.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offerings
7.4.5 SCITECH Medical Recent Development
7.5 Wellinq
7.5.1 Wellinq Company Information
7.5.2 Wellinq Introduction and Business Overview
7.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Wellinq Coronary Intervention Drug Eluting Stent Product Offerings
7.5.5 Wellinq Recent Development
7.6 Degania Silicone
7.6.1 Degania Silicone Company Information
7.6.2 Degania Silicone Introduction and Business Overview
7.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Degania Silicone Coronary Intervention Drug Eluting Stent Product Offerings
7.6.5 Degania Silicone Recent Development
7.7 Alvimedica
7.7.1 Alvimedica Company Information
7.7.2 Alvimedica Introduction and Business Overview
7.7.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Alvimedica Coronary Intervention Drug Eluting Stent Product Offerings
7.7.5 Alvimedica Recent Development
7.8 Interventional Medical Device Solutions
7.8.1 Interventional Medical Device Solutions Company Information
7.8.2 Interventional Medical Device Solutions Introduction and Business Overview
7.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offerings
7.8.5 Interventional Medical Device Solutions Recent Development
7.9 Comed BV
7.9.1 Comed BV Company Information
7.9.2 Comed BV Introduction and Business Overview
7.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Comed BV Coronary Intervention Drug Eluting Stent Product Offerings
7.9.5 Comed BV Recent Development
7.10 iVascular
7.10.1 iVascular Company Information
7.10.2 iVascular Introduction and Business Overview
7.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.10.4 iVascular Coronary Intervention Drug Eluting Stent Product Offerings
7.10.5 iVascular Recent Development
7.11 LEPU Medical
7.11.1 LEPU Medical Company Information
7.11.2 LEPU Medical Introduction and Business Overview
7.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.11.4 LEPU Medical Coronary Intervention Drug Eluting Stent Product Offerings
7.11.5 LEPU Medical Recent Development
7.12 Eurocor Tech GmbH
7.12.1 Eurocor Tech GmbH Company Information
7.12.2 Eurocor Tech GmbH Introduction and Business Overview
7.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offerings
7.12.5 Eurocor Tech GmbH Recent Development
7.13 OrbusNeich
7.13.1 OrbusNeich Company Information
7.13.2 OrbusNeich Introduction and Business Overview
7.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.13.4 OrbusNeich Coronary Intervention Drug Eluting Stent Product Offerings
7.13.5 OrbusNeich Recent Development
7.14 Endocor GmbH
7.14.1 Endocor GmbH Company Information
7.14.2 Endocor GmbH Introduction and Business Overview
7.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offerings
7.14.5 Endocor GmbH Recent Development
7.15 Meril Life Sciences
7.15.1 Meril Life Sciences Company Information
7.15.2 Meril Life Sciences Introduction and Business Overview
7.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offerings
7.15.5 Meril Life Sciences Recent Development
7.16 Acrostak
7.16.1 Acrostak Company Information
7.16.2 Acrostak Introduction and Business Overview
7.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Acrostak Coronary Intervention Drug Eluting Stent Product Offerings
7.16.5 Acrostak Recent Development
7.17 Boston Scientific Corporation
7.17.1 Boston Scientific Corporation Company Information
7.17.2 Boston Scientific Corporation Introduction and Business Overview
7.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offerings
7.17.5 Boston Scientific Corporation Recent Development
7.18 B. Braun
7.18.1 B. Braun Company Information
7.18.2 B. Braun Introduction and Business Overview
7.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.18.4 B. Braun Coronary Intervention Drug Eluting Stent Product Offerings
7.18.5 B. Braun Recent Development
7.19 Biotronik
7.19.1 Biotronik Company Information
7.19.2 Biotronik Introduction and Business Overview
7.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Biotronik Coronary Intervention Drug Eluting Stent Product Offerings
7.19.5 Biotronik Recent Development
7.20 Abbott
7.20.1 Abbott Company Information
7.20.2 Abbott Introduction and Business Overview
7.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Abbott Coronary Intervention Drug Eluting Stent Product Offerings
7.20.5 Abbott Recent Development
7.21 MicroPort Medical Group
7.21.1 MicroPort Medical Group Company Information
7.21.2 MicroPort Medical Group Introduction and Business Overview
7.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.21.4 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offerings
7.21.5 MicroPort Medical Group Recent Development
7.22 Philips
7.22.1 Philips Company Information
7.22.2 Philips Introduction and Business Overview
7.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Philips Coronary Intervention Drug Eluting Stent Product Offerings
7.22.5 Philips Recent Development
7.23 Terumo Corporation
7.23.1 Terumo Corporation Company Information
7.23.2 Terumo Corporation Introduction and Business Overview
7.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offerings
7.23.5 Terumo Corporation Recent Development
8 Industry Chain Analysis
8.1 Coronary Intervention Drug Eluting Stent Industrial Chain
8.2 Coronary Intervention Drug Eluting Stent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Coronary Intervention Drug Eluting Stent Sales Model
8.5.2 Sales Channel
8.5.3 Coronary Intervention Drug Eluting Stent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Coronary Intervention Drug Eluting Stent Market Trends
    Table 2. Coronary Intervention Drug Eluting Stent Market Drivers & Opportunity
    Table 3. Coronary Intervention Drug Eluting Stent Market Challenges
    Table 4. Coronary Intervention Drug Eluting Stent Market Restraints
    Table 5. Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company (2019-2024)
    Table 7. Global Coronary Intervention Drug Eluting Stent Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Coronary Intervention Drug Eluting Stent Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Coronary Intervention Drug Eluting Stent Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Coronary Intervention Drug Eluting Stent Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Coronary Intervention Drug Eluting Stent
    Table 13. Global Coronary Intervention Drug Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Intervention Drug Eluting Stent as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Coronary Intervention Drug Eluting Stent Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Coronary Intervention Drug Eluting Stent Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Coronary Intervention Drug Eluting Stent Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Coronary Intervention Drug Eluting Stent Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Coronary Intervention Drug Eluting Stent Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Coronary Intervention Drug Eluting Stent Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Coronary Intervention Drug Eluting Stent Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Coronary Intervention Drug Eluting Stent Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Coronary Intervention Drug Eluting Stent Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Coronary Intervention Drug Eluting Stent Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Coronary Intervention Drug Eluting Stent Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Coronary Intervention Drug Eluting Stent Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Coronary Intervention Drug Eluting Stent Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Coronary Intervention Drug Eluting Stent Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Coronary Intervention Drug Eluting Stent Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Coronary Intervention Drug Eluting Stent Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Coronary Intervention Drug Eluting Stent Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Coronary Intervention Drug Eluting Stent Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2019-2024) & (%)
    Table 44. Global Coronary Intervention Drug Eluting Stent Sales Value by Region (2025-2030) & (%)
    Table 45. Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Coronary Intervention Drug Eluting Stent Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Coronary Intervention Drug Eluting Stent Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Coronary Intervention Drug Eluting Stent Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Volume, (2025-2030) & (K Units)
    Table 57. Synlas GmbH Company Information
    Table 58. Synlas GmbH Introduction and Business Overview
    Table 59. Synlas GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offerings
    Table 61. Synlas GmbH Recent Development
    Table 62. YILSON Company Information
    Table 63. YILSON Introduction and Business Overview
    Table 64. YILSON Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. YILSON Coronary Intervention Drug Eluting Stent Product Offerings
    Table 66. YILSON Recent Development
    Table 67. BrosMed Medical Company Information
    Table 68. BrosMed Medical Introduction and Business Overview
    Table 69. BrosMed Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offerings
    Table 71. BrosMed Medical Recent Development
    Table 72. SCITECH Medical Company Information
    Table 73. SCITECH Medical Introduction and Business Overview
    Table 74. SCITECH Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offerings
    Table 76. SCITECH Medical Recent Development
    Table 77. Wellinq Company Information
    Table 78. Wellinq Introduction and Business Overview
    Table 79. Wellinq Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Wellinq Coronary Intervention Drug Eluting Stent Product Offerings
    Table 81. Wellinq Recent Development
    Table 82. Degania Silicone Company Information
    Table 83. Degania Silicone Introduction and Business Overview
    Table 84. Degania Silicone Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Degania Silicone Coronary Intervention Drug Eluting Stent Product Offerings
    Table 86. Degania Silicone Recent Development
    Table 87. Alvimedica Company Information
    Table 88. Alvimedica Introduction and Business Overview
    Table 89. Alvimedica Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Alvimedica Coronary Intervention Drug Eluting Stent Product Offerings
    Table 91. Alvimedica Recent Development
    Table 92. Interventional Medical Device Solutions Company Information
    Table 93. Interventional Medical Device Solutions Introduction and Business Overview
    Table 94. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offerings
    Table 96. Interventional Medical Device Solutions Recent Development
    Table 97. Comed BV Company Information
    Table 98. Comed BV Introduction and Business Overview
    Table 99. Comed BV Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Comed BV Coronary Intervention Drug Eluting Stent Product Offerings
    Table 101. Comed BV Recent Development
    Table 102. iVascular Company Information
    Table 103. iVascular Introduction and Business Overview
    Table 104. iVascular Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. iVascular Coronary Intervention Drug Eluting Stent Product Offerings
    Table 106. iVascular Recent Development
    Table 107. LEPU Medical Company Information
    Table 108. LEPU Medical Introduction and Business Overview
    Table 109. LEPU Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. LEPU Medical Coronary Intervention Drug Eluting Stent Product Offerings
    Table 111. LEPU Medical Recent Development
    Table 112. Eurocor Tech GmbH Company Information
    Table 113. Eurocor Tech GmbH Introduction and Business Overview
    Table 114. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offerings
    Table 116. Eurocor Tech GmbH Recent Development
    Table 117. OrbusNeich Company Information
    Table 118. OrbusNeich Introduction and Business Overview
    Table 119. OrbusNeich Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. OrbusNeich Coronary Intervention Drug Eluting Stent Product Offerings
    Table 121. OrbusNeich Recent Development
    Table 122. Endocor GmbH Company Information
    Table 123. Endocor GmbH Introduction and Business Overview
    Table 124. Endocor GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offerings
    Table 126. Endocor GmbH Recent Development
    Table 127. Meril Life Sciences Company Information
    Table 128. Meril Life Sciences Introduction and Business Overview
    Table 129. Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offerings
    Table 131. Meril Life Sciences Recent Development
    Table 132. Acrostak Company Information
    Table 133. Acrostak Introduction and Business Overview
    Table 134. Acrostak Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Acrostak Coronary Intervention Drug Eluting Stent Product Offerings
    Table 136. Acrostak Recent Development
    Table 137. Boston Scientific Corporation Company Information
    Table 138. Boston Scientific Corporation Introduction and Business Overview
    Table 139. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offerings
    Table 141. Boston Scientific Corporation Recent Development
    Table 142. B. Braun Company Information
    Table 143. B. Braun Introduction and Business Overview
    Table 144. B. Braun Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. B. Braun Coronary Intervention Drug Eluting Stent Product Offerings
    Table 146. B. Braun Recent Development
    Table 147. Biotronik Company Information
    Table 148. Biotronik Introduction and Business Overview
    Table 149. Biotronik Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Biotronik Coronary Intervention Drug Eluting Stent Product Offerings
    Table 151. Biotronik Recent Development
    Table 152. Abbott Company Information
    Table 153. Abbott Introduction and Business Overview
    Table 154. Abbott Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Abbott Coronary Intervention Drug Eluting Stent Product Offerings
    Table 156. Abbott Recent Development
    Table 157. MicroPort Medical Group Company Information
    Table 158. MicroPort Medical Group Introduction and Business Overview
    Table 159. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offerings
    Table 161. MicroPort Medical Group Recent Development
    Table 162. Philips Company Information
    Table 163. Philips Introduction and Business Overview
    Table 164. Philips Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Philips Coronary Intervention Drug Eluting Stent Product Offerings
    Table 166. Philips Recent Development
    Table 167. Terumo Corporation Company Information
    Table 168. Terumo Corporation Introduction and Business Overview
    Table 169. Terumo Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offerings
    Table 171. Terumo Corporation Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Coronary Intervention Drug Eluting Stent Downstream Customers
    Table 175. Coronary Intervention Drug Eluting Stent Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Coronary Intervention Drug Eluting Stent Product Picture
    Figure 2. Global Coronary Intervention Drug Eluting Stent Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Coronary Intervention Drug Eluting Stent Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Coronary Intervention Drug Eluting Stent Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Coronary Intervention Drug Eluting Stent Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Coronary Intervention Drug Eluting Stent Report Years Considered
    Figure 7. Global Coronary Intervention Drug Eluting Stent Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Coronary Intervention Drug Eluting Stent Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Coronary Intervention Drug Eluting Stent Revenue in 2023
    Figure 10. Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Below 40 µm Picture
    Figure 12. 40 µm- 65 µm Picture
    Figure 13. Above 65 µm Picture
    Figure 14. Global Coronary Intervention Drug Eluting Stent Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Coronary Intervention Drug Eluting Stent Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Coronary Intervention Drug Eluting Stent Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Coronary Intervention Drug Eluting Stent Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Coronary Intervention Drug Eluting Stent Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Product Picture of Others
    Figure 22. Global Coronary Intervention Drug Eluting Stent Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Coronary Intervention Drug Eluting Stent Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Coronary Intervention Drug Eluting Stent Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Coronary Intervention Drug Eluting Stent Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Coronary Intervention Drug Eluting Stent Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Coronary Intervention Drug Eluting Stent Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Coronary Intervention Drug Eluting Stent Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Coronary Intervention Drug Eluting Stent Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Coronary Intervention Drug Eluting Stent Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Coronary Intervention Drug Eluting Stent Sales Volume (%), (2019-2030)
    Figure 39. United States Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Coronary Intervention Drug Eluting Stent Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Coronary Intervention Drug Eluting Stent Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Coronary Intervention Drug Eluting Stent Sales Value by Application (%), 2023 VS 2030
    Figure 60. Coronary Intervention Drug Eluting Stent Industrial Chain
    Figure 61. Coronary Intervention Drug Eluting Stent Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart